Pay attention to how your body reacts, especially during the initial stages of treatment
Pediatr Res 96(3):632642 Ali I, Adil M, Imran M, Qureshi SA, Qureshi S, Hasan N, Ahmad FJ (2025) Nanotechnology in Parkinsons disease: overcoming drug delivery challenges and enhancing therapeutic outcomes
Its not a hormone or a painkiller
GLP-1 receptor agonists (glucagon-like peptide-1) are a class of medications that mimic a natural hormone in your body
The American Diabetes Association recommends regular screening for DPN at the time of diabetes diagnosis in type 2 diabetes (T2D) and 5 years after diagnosis in type 1 diabetes (T1D) and annually thereafter
Programmed cell death, from a cancer perspective: an overview